Did you know that the “four-hit” hypothesis for IgA nephropathy #IgAN was first clearly articulated by Hitoshi Suzuki et al. in their 2011 J. Am. Soc. Nephrol. paper, “The pathophysiology of IgA nephropathy.”
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/21949093/
Therapeutic targets 🎯and positioning of treatments in IgA nephropathy 🔬 #IgAN ca. 2026 from @kidneyint.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41895685/
Efficacy and Safety of Atrasentan in Patients with #IgAN Receiving Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) ca. 2026 from @asnpublications.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
Photo Credit: @nephroseeker.medsky.social
👉 journals.lww.com/jasn/fulltex...
I made it to #ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 ... well, kinda ...
Photo Credit 👉 @hswapnil.medsky.social
pubmed.ncbi.nlm.nih.gov/35155869/
Trying to catch up with #IgAN trials⁉️
Check out 👉 “IgAN: An Overview of the Clinical Trials” ca. 2025 from @kidneymed.bsky.social @haresh11.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41050133/
SGLT2 inhibition: Pleiotropic direct cardiac and kidney effects ⁉️
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/35589167/
The draft of the @kdigo.org 2026 Clinical Practice Guideline for Acute Kidney Injury and Acute Kidney Disease is now available for public review through 🗓️ April 27, 2026
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉 kdigo.org/guidelines/a...
👉 FEEDBACK Form www.surveymonkey.com/r/GTGNFHG
Approach to immune checkpoint inhibitor (ICI) nephrotoxicity and rechallenge
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/32775813/
Diagnostic approach to hypophosphatemia
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/34754427/
Practical suggestions for the diagnosis and management of hypertension before, during, and after the start of anticancer therapy
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/36621810/
Cancer Therapy Related Hypertension
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/36621810/
Pathogenesis of IgA Nephropathy #IgAN
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/37742867/
Hypomagnesemia
📌 Manifestations and its association with cancer
📌 Causes in patients with cancer
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/37086496/
Individualized management of malignancy-associated hypercalcemia
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Onconephrology 🦀 #Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/41623290/
Pillars of IgA Nephropathy #IgAN Treatment
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/38398259/
Pillars of Treatment for Diabetic Kidney Disease secondary to Type 2 Diabetes (T2D)
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵
#Nephpearls #NephSky
👉🏼 medicinetoday.com.au/mt/2024/dece...
Timely publication on "@asnkidney.bsky.social Kidney Health Guidance on Conservative Management in People with Kidney Failure" ca. 2026 from @asnpublications.bsky.social
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41848800/
Cardiovascular-Kidney-Metabolic (CKM) Syndrome Stages: Identify Chronic Kidney Disease (CKD) as an important risk ⚠️ for adverse outcomes
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/37807924/
If you're attending #WCN26 🇯🇵 #WCN2026 🇯🇵 do not miss @kdigo.org Guideline Education Meeting (GEM) #KDIGOGEMS 💎
#Nephpearls #NephSky
🗓️ Friday, March 27, 2026
⏰ 09:00 – 16:00 JST
📍 Room 303, Pacifico Yokohama Conference Center
Learn more: kdigo.co/WCN26-KDIGO-...
In conjunction w/ @theisn.org
World Congress of Nephrology & Tokushukai Medical Group, @kdigo.org will host a full-day Guideline Education Meeting (GEM)
#ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #KDIGOGEMS 💎 #NephSky
👉🏼 kdigo.org/events/kdigo...
Are you attending #WCN26? Join KDIGO and Tokushukai Medical Group for a full-day KDIGO Guideline Education Meeting (GEM) focused on translating the latest KDIGO Guidelines into practical, patient-centered care.
Friday, March 27, 2026, 09:00 – 16:00 hrs JST.
Learn more: kdigo.co/WCN26-GEM-Sy...
KDIGO Direct newsletter logo
Check out the February issue of KDIGO Direct for the latest news and resources from KDIGO: kdigo.co/KDIGO-Direct...
In this issue:
- KDIGO at #WCN26
- Open Call for KDIGO Methods Committee
- Upcoming activities
- New resources in anemia, CKD, CVD, genetic testing, and more
